CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial Of Ofatumumab In Older (≥70 Years) Patients With Previously Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01263418
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:05.985426+00:00
Published At: 2015-10-12T00:00:00+00:00
Record Updated At: 2015-10-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lymphoma, Non-Hodgkin", "Lymphoma, Follicular", "Lymphoma, B-Cell, Marginal Zone", "Lymphoma, Low-Grade", "Lymphoma, Intermediate-Grade"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-10-12"
protocolSection.identificationModule.nctId: "NCT01263418"
protocolSection.identificationModule.officialTitle: "A Phase II Trial Of Ofatumumab In Older (\u226570 Years) Patients With Previously Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.